Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Comparison of mean CEA and CA19-9 values by age groups | Download Table
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19- 9 in Colorectal Cancer
CA19-9 Levels in Saliva and Urine of Patients with Ductal Adenocarcinoma of the Pancreas Correlates with Serum CA19-9 Levels - A Prospective Preliminary Study
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
AFP, CEA, CA 19-9 and TPA in Hepatocellular Carcinoma | Semantic Scholar
Tumor Markers:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
Tumor markers in clinical practice Colorectal - CEA Hepatocellular ... | GrepMed
Extremely high serum level of carbohydrate antigen 19-9 in a patient with colon adenocarcinoma
CA-19-9 - Diagnostic Kit
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
CA 19-9 Antigen - an overview | ScienceDirect Topics
Serum levels of CEA and CA19.9 tumor markers in individual patients | Download Table
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19- 9 in Colorectal Cancer
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Comparison between CEA, CA 19-9 and CA 72-4 in Patients with Colon Cancer
